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Abstract  
Objectives: Cancer stigma can have widespread effects, influencing the behaviour and 
wellbeing of patients as well as the community and even research funding.  Patients with 
lung cancer report feeling particularly stigmatised because of the association with a 
behaviour (smoking) that is perceived to be personally controllable.  However there are other 
dimensions of cancer stigma, that might be more severe for other cancers.  The present 
study therefore examined differences in attitudes towards lung cancer and four other cancer 
types, using a multidimensional measure of cancer stigma, to extend findings beyond 
personal responsibility attributions. 
   
Materials and methods: Participants were a non-patient sample (n=1205) who were 
randomised to complete a survey online relating to one of five cancer types (lung, colorectal, 
skin, breast and cervical).  Stigma was assessed using the Cancer Stigma Scale (CASS).   
 
Results: There were significant differences across the five cancer types on all CASS 
subscales: awkwardness (F(4, 1009)=5.16, p<.001), severity (F(4, 984)=26.24, p<.001), 
avoidance (F(4, 1008)=5.38, p<.001), policy opposition (F(4, 1009)=8.38, p<.001), personal 
responsibility (F(4, 995)=31.67, p<.001) and financial discrimination (F(4, 957)=9.45, 
p<.001).  Lung cancer attracted higher stigma scores than breast and cervical cancer on all 
subscales.  Lung cancer was similar to skin cancer on personal responsibility, avoidance, 
and policy opposition, but attracted higher stigma in the domains of awkwardness, severity 
and financial discrimination.  Lung cancer was similar to colorectal cancer for awkwardness, 
but significantly higher on all other subscales.   
 
Conclusion: Lung cancer stigma extends beyond personal responsibility attributions to other 
dimensions, particularly perceived severity of the disease and tolerance of financial 
discrimination against patients with the disease.  Future work is needed to develop and 
evaluate interventions designed to limit cancer stigma for patients, health professionals and 
the community.  Health policies should acknowledge the existence of lung cancer stigma and 
make a commitment to minimising this.    
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Introduction 
 
Research into public perceptions of cancer suggests that it is often appraised more 
negatively than other serious illnesses such as heart disease [1;2]; attracting a particular 
sense of dread.  In a large representative sample of the US population, 61% of adults agreed 
that when they think of cancer they automatically think of death [3], and a quarter thought 5-
year cancer survival rates were 25% or less [4], despite the overall 5-year figure being 68% 
[5].  Studies with cancer patients and health professionals suggest that lung cancer in 
particular attracts stigma because of its poor prognosis and established link with smoking 
[6;7].  Recent decades have seen an increase in tobacco control policy initiatives, which aim 
to de-normalise smoking [8].  Initiatives include bans on smoking in public places and mass 
media campaigns persuading smokers to stop, often by using graphic images and emotional 
appeals.  These have successfully shifted public perceptions, with smoking now widely seen 
as undesirable.  In qualitative work non-smokers described smoking as ‘dirty’, ‘anti-social’ 
and ‘unacceptable’ [9], and just under two-thirds of non-smokers say they would mind if 
someone smoked near them [10].  This shift in perceptions has resulted in dramatic 
decreases in smoking prevalence in most high-income countries.  With most lung cancers 
caused by smoking, and high public awareness of this, lung cancer is often seen as a self-
inflicted illness and negative attitudes to smoking, as a result of health policy and promotion 
over the last twenty years, have arguably contributed to the stigmatisation of lung cancer 
patients [7].   
 
Goffman’s classic definition of stigma defined it as an attribute that makes a person different 
from others and results in them being discredited [11].  Link and Phelan agree that stigma 
occurs when a difference that is considered salient is labelled, this labelled difference is 
associated with negative attributes, those with the label are seen as a separate group (‘them 
versus us’) and the label results in loss of status or discrimination [12].  In line with these 
definitions, lung cancer patients may be seen as distinct from other cancer patients because 
they are assumed to be smokers with smoking seen as a negative attribute.  In a vignette 
study, participants were randomised to read about a lung cancer patient with a genetic, 
smoking or combined cause [13]; patients in the genetic condition were attributed less 
personal responsibility, less anger and more pity than those with a smoking-related or 
combined cause.  Similar findings have been shown with other cancers that have controllable 
causes, for example in another vignette study, participants were randomised to read about a 
patient with cervical cancer (caused by a sexually transmitted infection) or ovarian cancer 
(caused by family history) [14]; the patient with cervical cancer was judged more negatively 
(considered more dirty, dishonest and unwise), and attracted more moral disgust.     
 
Else-Quest et al [15] compared perceived stigma scores (agreement with the statement: 
‘People judge me for my cancer type’) in patients with lung, breast and prostate cancer. 
Scores were highest for lung cancer, lowest for breast cancer and in between for prostate 
cancer, although group differences were not significant.  In a general population survey, a 
large sample of women were asked to indicate how much they would blame someone with 
lung, colorectal, breast, cervical cancer or leukaemia [16].  Consistent with previous work, 
lung cancer attracted the highest blame scores (mean rank: 4.9), while breast cancer and 
leukaemia attracted the lowest scores (mean ranks: 2.7 and 2.5).   
 
Stigma of cancer can influence engagement with prevention behaviours [17-19], help-
seeking behaviours in the presence of symptoms [20;21], disclosure of the disease [6;22], 
and wellbeing following a diagnosis [23;24].  For lung cancer in particular, recent work has 
shown that higher stigma is associated with greater depression and lower quality of life and 
this is the case among smokers and non-smokers [25].   Stigma could also affect community-
wide responses to people who have cancer [26] and charitable donations to support research 
funding [27].  Previous studies have focused on personal responsibility judgements as a 
means of operationalizing lung cancer stigma.  The aim of the present study was to take a 
 3 
 
broader perspective using a multidimensional scale to explore stigma between lung cancer 
and four other cancer types.   
 
Materials and methods 
 
Participants 
Participants were recruited through an online survey panel.  The panel was supplied by 
Survey Sampling International, who hold a panel of participants willing to complete online 
questionnaires in exchange for small incentives (e.g. air miles).  At the time of recruitment, 
their panel size was almost 250,000, of whom 57% were female, 66% were between 18 and 
44 years old, and 23% had a university degree.  The sample directed to our questionnaire 
was representative of the UK population in terms of gender, age and locality.  The study was 
approved by the UCL Research Ethics Committee.   
 
Procedure 
Participants were randomised to respond for one of five cancer types: lung, cervical, breast, 
skin or colorectal cancer (referred to as bowel cancer).  We estimated that 200 participants in 
each group would give us approximately 80% power to detect a significant difference of 0.5 
(SD 1.2) between the least and most stigmatised cancer type (effect size f=0.105).  We 
commissioned data collection from 1200 panel participants (240 per cancer type) using quota 
stops to ensure a good gender and education balance in the sample.   
 
Measures 
Participants reported their age, gender, ethnicity and education level.  All completed the 25-
item Cancer Stigma Scale (CASS) for their randomised cancer type [28].  The CASS 
assesses multiple aspects of cancer stigma including: awkwardness (5-items, e.g. I would 
find it hard to talk to someone with cancer), severity (5-items, e.g. Getting cancer means 
having to mentally prepare oneself for death), avoidance (5-items, e.g. If a colleague had 
cancer I would try to avoid them), policy opposition (4-items, e.g. The needs of people with 
cancer should be given top priority), personal responsibility (4-items, e.g. If a person has 
cancer it’s probably their fault) and financial discrimination (3-items, e.g. It is acceptable for 
insurance companies to reconsider a policy if someone has cancer).  Responses for each 
item are made on a 6-point scale; ‘agree strongly’ to ‘disagree strongly’ or ‘yes, definitely’ to 
‘definitely not’ and reverse scored as needed.  Cronbach’s alpha scores in the present 
sample were >.7 for most of the subscales for each cancer type (awkwardness: 0.74-0.83; 
severity: 0.74-0.89; avoidance: 0.91-0.94; policy opposition: 0.61-0.77; personal 
responsibility: 0.91-0.95; financial discrimination: 0.76-0.82).   
 
Analyses 
Scores for each subscale were calculated by taking the mean of the items (potential range 1-
6).  Data were analysed in SPSS version 15.0.  Two-way between-groups ANOVAs were 
used to compare the mean scores for each cancer type.  Post-hoc tests (Tukey) were used 
to explore these differences in more detail; identifying whether lung and breast cancer 
differed from the other cancers.   
 
Results 
 
Sample characteristics 
Overall 1205 participants completed the questionnaire.  Cases with >20% missing data on 
the CASS were excluded (16%).  After exclusions, 1014 cases were available for further 
analyses: cervical cancer (n=187), lung cancer (n=204), breast cancer (n=213), colorectal 
cancer (n=195) and skin cancer (n=215).  Half the participants were female (49%) and the 
mean age was 37.8 years (range 16-80).  Sample characteristics are shown in Table 1.  
There were no significant differences in gender, age, ethnicity or educational attainment 
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across the five cancer types.  In general, stigma scores were at the lower end of the scale, 
with most mean scores for each subscale less than 3 on the 1-6 scales, see figure 1.   
 
Variation in stigma by cancer type 
There were significant differences in mean scores across the five cancer types for each of 
the six subscales: awkwardness (F(4, 1009)=5.16, p<.001), severity (F(4, 984)=26.24, 
p<.001), avoidance (F(4, 1008)=5.38, p<.001), policy opposition (F(4, 1009)=8.38, p<.001), 
personal responsibility (F(4, 995)=31.67, p<.001) and financial discrimination (F(4, 
957)=9.45, p<.001).  Lung cancer stigma was significantly greater than cervical and breast 
cancer stigma across all six subscales (p<.01), greater than colorectal cancer on all 
subscales except awkwardness (p<.05), and greater than skin cancer on awkwardness, 
severity and discrimination (p<.01).   
 
Breast cancer attracted lower stigma than most of the other cancer types.  Scores were 
significantly lower than lung cancer on all six subscales (p<.01), lower than skin cancer on 
three subscales (avoidance, p<.05; policy opposition, p<.05; personal responsibility, p<.001) 
and colorectal cancer on two subscales (severity, p<.05; personal responsibility, p<.01).  
Breast and cervical cancer were not significantly different on any of the subscales (p>.05).  
 
Discussion 
 
This study used a multidimensional measure of stigma to explore differences between lung 
cancer and four other cancer types.  As others have reported [6;15;16], the study participants 
saw lung cancer as more severe than other cancers, and were more likely to feel awkward 
around, and avoid, someone with lung cancer.  Lung cancer was attributed more personal 
responsibility than the other cancers (except for skin cancer).  In addition, there was less 
support for policy initiatives to protect lung cancer patients and more acceptance of financial 
discrimination.  Breast cancer attracted the least stigma across all six of the subscales, 
although it was not significantly different from cervical cancer and not always significantly 
lower than skin and colorectal cancer.  The remaining three cancer types (colorectal, skin 
and cervical cancer) mostly fell in between lung and breast cancer, but their patterning varied 
across the six subscales.   
 
Previous studies have suggested lung cancer stigma is driven by the perception that all lung 
cancer patients are smokers, meaning their illness is self-inflicted [7].  Health policy and 
media campaigns have successfully de-normalised smoking, and while this has had the 
desired effect on smoking prevalence, the step from stigmatising smoking to stigmatising 
lung cancer patients is often considered unjust.  Lung cancer stigma does not appear to be 
restricted to personal responsibility attributions and attempts to alleviate lung cancer stigma 
could help to improve the lung cancer patient experience.  Studies suggest that lung cancer 
patients feel ‘dirty’ and like ‘lepers’  [6] as well as suffering higher levels of distress [29] and 
suicide  compared to other cancer patients [30].  Chambers et al. [31] recently published the 
first study aimed at decreasing health-related stigma in lung cancer patients through 
telephone sessions delivering acceptance-focused cognitive behavioural therapy (CBT).  The 
intervention appeared to successfully reduce felt-stigma as well as distress and depression.   
 
A multi-level approach to interventions, aiming to change perceptions among the general 
public, family members and health professionals as well as patients might be beneficial, but 
research is needed to explore the best ways of doing this.  Studies of drug addiction stigma 
suggest that communicating positive stories about patients may be an effective way to 
influence social stigma, while contact-based training appears to be the best way to address 
stigma among health professionals [32].  Health policies should acknowledge the existence 
of lung cancer stigma and the multilevel consequences this has.  Acknowledgement of 
cancer stigma alongside commitment to minimising this will help encourage research 
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establishing the best ways to reduce lung cancer stigma and ultimately improve patient 
experience.   
 
There are limitations to the present study.  Admitting to cancer stigma is likely to be 
considered socially undesirable, and respondents may have adjusted their responses to 
portray a less negative attitude; but we believe that anonymity and use of online 
questionnaires should have limited social desirability effects [33].  Although the panel sample 
was demographically representative of the population, generalisations to the wider 
population about the level of cancer stigma may be limited. However, we would expect that 
the differences between the cancers would be at least as great in a population representative 
sample.   
 
Variation in scores on the stigma subscales was within a small range; in most cases the 
difference in mean scores between the most and the least stigmatised cancers was less than 
1 (on a 6-point scale).  Without further exploration of these findings, it is difficult to determine 
their social/behavioural significance.  Research exploring the association between responses 
on these scales and support for self-disclosure of cancer patients would be valuable.  In 
general stigma of cancer was low in the present sample; respondents did not think they 
would avoid or feel awkward around someone with cancer, they did not think someone with 
cancer was responsible for their illness or that the consequences of cancer were always 
severe, they did not endorse financial discrimination against people with cancer, and they 
supported funding and policies to help people with cancer.  These findings were not 
unexpected; our interest lay more in the variation between cancer types.    
 
Conclusion 
 
Most stigma theorists suggest that stigma varies across time and between cultures [34], but 
rarely consider how it varies across different subtypes of a disease. As public awareness 
about the causes and consequences of cancer increases, stigma may become a more 
important issue for some cancers.  There is a risk that increasing public awareness of 
‘lifestyle’ causes could increase stigma [26], but at the same time, if outcomes improve and 
the dread associated with cancer recedes, some aspects of cancer stigma may be reduced. 
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Table 1: Sample characteristics 
 Total 
(n=1205) 
Cervical 
(n=227) 
Lung 
(n=247) 
Breast 
(n=242) 
Colorectal 
(n=241) 
Skin 
(n=248) 
              
Age (mean) 37.8 39.2 36.7 37.1 38.9 37.0 
       
Gender (%)       
Female  49.3 50.7 46.2 47.9 53.9 48.0 
Male  50.7 49.3 53.8 52.1 46.1 52.0 
       
Ethnicity (%)       
White 87.0 91.8 88.4 87.2 89.1 84.6 
Non-white 11.7 8.2 11.6 12.8 10.9 15.4 
       
Education (%)        
GCSE or vocational  32.9 33.0 31.6 31.8 34.4 33.9 
A-level or higher qualification < degree 34.4 37.0 38.9 28.9 35.3 31.9 
Degree  28.2 24.2 25.1 35.5 25.7 30.2 
Other 4.5 5.7 4.5 3.7 4.6 4.0 
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